Crowdonomics
Bio Essence Corp

Reg A+ · Equity · Jan 2026

OpenReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$0 / $5M max
0% of ceiling
Investors
—
—
Momentum
$0/day
—

Financials disclosed in this offering

FY2024 · hover for source
$324K
−$1.3M
FY2024
RevenueNet income
Metric
FY2024 audited
Income statement
Revenue
$323,940
Cost of goods sold
$106,863
Gross margin
67%
Net income
-$1,308,796
Taxes paid
$800
Balance sheet
Cash
$1,371
Accounts receivable
$5,124
Total assets
$281,024
Long-term debt
$56,481
Total liabilities
$3,250,114
Other
Headcount
4

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Est. pre-money$1.9M
Price / share$0.05
Shares offered100,000,000

Estimated, not stated: $0.05 × 38,029,000 as-converted securities outstanding.

Offering details

Target—
Max$5,000,000
Min investment—
OpenedJan 5, 2026
Deadline—
Days active277

Links & provenance

Source: SEC EDGAR
0001213900-25-100050
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.